Latest news with #ScheduleIII
The Guardian
7 days ago
- Politics
- The Guardian
Trump reportedly considers reclassifying marijuana as less dangerous drug
Donald Trump is considering reclassifying marijuana as a less dangerous drug, the Wall Street Journal reported on Friday, citing people familiar with the matter. At a $1m-a-plate fundraiser at his New Jersey golf club earlier this month, Trump told attendees he was interested in making such a change, the people, who declined to be named, told the newspaper. The reclassification, to remove marijuana from the list of Schedule I controlled substances and make it a Schedule III drug, was proposed by the Biden administration, but not enacted. The change would make it much easier to buy and sell marijuana and make the legal multibillion-dollar industry more profitable. The guests at Trump's fundraiser included Kim Rivers, chief executive of Trulieve, one of the largest marijuana companies, who encouraged Trump to pursue the change and expand medical marijuana research, the report said. During Trump's first term, two Soviet-born Republican donors, Lev Parnas and Igor Fruman, directly appealed to Trump for help with their plan to sell marijuana in states where recreational use was legal. Audio of the 2018 dinner, which was secretly recorded by the two men, revealed that Trump was skeptical, telling the two men that he believed marijuana use 'does cause an IQ problem; you lose IQ points'. In the same conversation, the Ukrainian-born Parnas first suggested to Trump that he should remove the US ambassador to Ukraine, Marie Yovanovitch, and shared a false rumor that the diplomat was badmouthing the president by 'telling everybody, 'Wait, he's gonna get impeached.'' Parnas and Fruman later helped Rudy Giuliani search for dirt on Joe Biden in Ukraine, before being indicted and found guilty of campaign finance violations, for secretly using a Russian oligarch's money to donate hundreds of thousands of dollars to Republican campaigns and committees, including Trump's, in pursuit of favors for their planned legal marijuana business. Reuters contributed reporting
The Guardian
09-08-2025
- Politics
- The Guardian
Trump reportedly considers reclassifying marijuana as less dangerous drug
Donald Trump is considering reclassifying marijuana as a less dangerous drug, the Wall Street Journal reported on Friday, citing people familiar with the matter. At a $1m-a-plate fundraiser at his New Jersey golf club earlier this month, Trump told attendees he was interested in making such a change, the people, who declined to be named, told the newspaper. The reclassification, to remove marijuana from the list of Schedule I controlled substances and make it a Schedule III drug, was proposed by the Biden administration, but not enacted. The change would make it much easier to buy and sell marijuana and make the legal multibillion-dollar industry more profitable. The guests at Trump's fundraiser included Kim Rivers, chief executive of Trulieve, one of the largest marijuana companies, who encouraged Trump to pursue the change and expand medical marijuana research, the report said. During Trump's first term, two Soviet-born Republican donors, Lev Parnas and Igor Fruman, directly appealed to Trump for help with their plan to sell marijuana in states where recreational use was legal. Audio of the 2018 dinner, which was secretly recorded by the two men, revealed that Trump was skeptical, telling the two men that he believed marijuana use 'does cause an IQ problem; you lose IQ points'. In the same conversation, the Ukrainian-born Parnas first suggested to Trump that he should remove the US ambassador to Ukraine, Marie Yovanovitch, and shared a false rumor that the diplomat was badmouthing the president by 'telling everybody, 'Wait, he's gonna get impeached.'' Parnas and Fruman later helped Rudy Giuliani search for dirt on Joe Biden in Ukraine, before being indicted and found guilty of campaign finance violations, for secretly using a Russian oligarch's money to donate hundreds of thousands of dollars to Republican campaigns and committees, including Trump's, in pursuit of favors for their planned legal marijuana business. Reuters contributed reporting
Wall Street Journal
02-07-2025
- Politics
- Wall Street Journal
Legal Marijuana's Disastrous Legacy
Whether to loosen the government's ultratight controls on marijuana is among the matters President Trump inherited from Joe Biden. Under law, marijuana is a Schedule I substance, meaning it has no accepted medical use and a high potential for abuse. Mr. Biden initiated a process to move pot to Schedule III, thereby labeling it a medicine with only moderate abuse potential. Mr. Trump must decide whether to move ahead with the change.
Hamilton Spectator
27-06-2025
- Hamilton Spectator
Vaughan man accused by Halton police of being mastermind behind fraud scheme that stole $150K from Burlington bank account
A man from Vaughan has been accused by Halton police as being the mastermind behind a fraud scheme that swindled more than $150,000 from a Burlington bank account. A suspect was arrested in March 2024 after investigators were contacted regarding a series of fraudulent withdrawals totalling $156,000 from an account at an HSBC branch, say police. The investigation continued and police say officers identified 'an additional suspect who organized the crime.' According to police, the suspect used a fake Ontario driver's licence to gain access to the bank account and then made large withdrawals via cash and wire transfers. A search warrant was carried out at the suspect's Vaughan home on June 26, where police say a large quantity of psilocybin and a prohibited .22-calibre rifle were seized. The suspect was also arrested at that time. A 41-year-old man from Vaughan has been charged with fraud over $5,000, possession of a Schedule III substance (psilocybin), careless use of a firearm, unauthorized possession of a firearm and breach of a firearm prohibition order. Anyone with more information is asked to call 905-825-4777 . Error! Sorry, there was an error processing your request. There was a problem with the recaptcha. Please try again. You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy . This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply. Want more of the latest from us? Sign up for more at our newsletter page .
Yahoo
30-04-2025
- Business
- Yahoo
Why Curaleaf Holdings Stock Rocketed Almost 20% Higher Today
The push to effectively legalize the drug in the U.S. seemed to get a major boost from the nominee to head the Drug Enforcement Agency. He pledged that reviewing federal policy on the drug will be at the top of his to-do list if he's confirmed. Wednesday was one of the rare good days for the beleaguered marijuana industry, with stocks in the sector experiencing significant lifts. One weedie that saw quite the price gain on the day was multistate operator Curaleaf Holdings (OTC: CURLF), which booked a nearly 20% increase. That compared most favorably to the sleepy S&P 500 index's less than 0.2% improvement. To a great degree, the future success of Curaleaf and its peers depends on the development of marijuana legalization in this country. At the moment, federal officials are contemplating a proposed rescheduling of the drug, from its most hazardous Schedule I category to the far milder grouping of Schedule III. This would, for all intents and purposes, make the drug legal nationwide. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » That potential change seemed to gain significant momentum on Wednesday during a confirmation hearing before the U.S. Senate's Judiciary Committee. President Donald Trump's nominee to lead the Drug Enforcement Administration (DEA), Terrance Cole, stated that reviewing the proposal will be one of his top priorities upon arrival at the DEA, if confirmed by the legislative body. Although marijuana advocates and cannabis company investors were excited when the proposal was first formally introduced, many have been frustrated by its slow progress up the legal ladder. Cole's remarks indicate that, at the very least, he'll prioritize the matter. Marijuana company shareholders (and those now contemplating an investment in the sector) should be careful here, though. Even though Senators from the committee pressed Cole on how he might approach rescheduling, he declined to commit to approving it. He told them that he needs "to understand more where [agencies] are and look at the science behind it and listen to the experts and really understand where they are in the process." Before you buy stock in Curaleaf, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Curaleaf wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $607,048!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $668,193!* Now, it's worth noting Stock Advisor's total average return is 880% — a market-crushing outperformance compared to 161% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of April 28, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why Curaleaf Holdings Stock Rocketed Almost 20% Higher Today was originally published by The Motley Fool
